CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank21
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Percentile
P21
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-29.83M+35.2%
2024$-46.00M-2.6%
2023$-44.83M-5.3%
2022$-42.57M-143.0%
2021$-17.52M-201.7%
2020$17.23M+276.6%
2019$-9.76M-126.1%
2018$37.34M-36.2%
2017$58.55M+228.3%
2016$17.83M-